TP53 and neoplasm: In our in vitro experimental model, the concentrations of 10 mM Cnt and 10 mM C2Cnt determined an alteration of the metabolic pathway, which could explain the anti-tumor effects, with differences between the two cell lines, likely due to the p53 status.